This company has shut down. Pear Therapeutics is no longer operating — its last tracked round was a Post-IPO Equity in 2021.
Explore the Startup GraveyardPear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Pear Therapeutics has raised $125.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2021.
Pear Therapeutics's investors include Temasek, Perceptive Advisors, Novartis, SoftBank Vision Fund, Neuberger Berman.
Pear Therapeutics is headquartered in Boston, United States.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Pear Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pear Therapeutics — Funding & Investors." VCBacked, December 6, 2021, https://www.vcbacked.co/company/pear-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Pear Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pear-therapeutics
{{cite web |title=Pear Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pear-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated